TIDMCVSG

RNS Number : 4555P

CVS Group plc

09 October 2023

Immediate release

9 October 2023

CVS Group Plc

("CVS", the "Company" or the "Group")

Exercise of Options, PDMR Dealing, EBT Share Purchase and Total Voting Rights

CVS, the UK listed veterinary group and a leading provider of veterinary services, announces that on 6 October 2023, options over a total of 107,903 new Ordinary shares of 0.2 pence each (the "New shares") were exercised under the CVS Group 2020 Long Term Incentive Plan ("LTIP 14"), at an exercise price of 0.2 pence.

Richard Fairman, Chief Executive Officer, Ben Jacklin, Deputy CEO, and Robin Alfonso, Chief Financial Officer, exercised options over 41,030, 24,618 and 13,540 Ordinary shares of 0.2p each in the Company ("Ordinary shares") respectively. The balance of the options was exercised by certain other employees of the Company.

On 6 October 2023, the Company was notified by JTC Employer Solutions Trustee Limited, the trustee of the CVS Group Employee Benefit Trust (the "EBT"), that the EBT had purchased a total of 56,896 of the New shares from LTIP 14 option-holders at a volume-weighted average price of GBP16.17 per Ordinary share. This included the purchase of shares by the EBT from Richard Fairman, Ben Jacklin and Robin Alfonso to meet the costs of exercise incurred by them as PDMR option-holders, including personal taxation, as set out below:

   Name                                    Number of shares sold to EBT                    Price 

Richard Fairman 19,510 GBP16.17

Ben Jacklin 11,706 GBP16.17

Robin Alfonso 6,439 GBP16.17

The New shares purchased by the EBT are intended to be used to satisfy the exercise of share options by employees. The EBT is a discretionary trust for the benefit of the Company's employees, including the Directors of the Company. The purchase of the New shares by the EBT has been funded from the Company's existing cash reserves. Following this transaction, a total of 57,280 Ordinary shares are held by the EBT, representing approximately 0.08% of the Company's total voting rights.

Admission of the New shares, which rank pari passu in all respects with the Company's existing Ordinary shares, has been satisfied by the Company's block listing admitted to the London Stock Exchange on 15 May 2023.

Following the issue of the New shares, the Company has a total issued share capital of 71,537,662 Ordinary shares each carrying one voting right. The Company holds no Ordinary shares in treasury. Therefore, following the issue of the New shares, the total number of voting rights in the Company will be 71,537,662. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Following their respective option exercises, their sales of a portion of the New shares arising and admission of the New shares, the Executive Directors, together with their respective spouses, hold a beneficial interest in the following Ordinary shares in the Company:

Name Number of shares Percentage interest in the Company

Richard Fairman 77,501 0.108%

Ben Jacklin 36,714 0.051%

Robin Alfonso 19,252 0.027%

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

Contacts:

CVS Group plc via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Ben Wright / James Thompson / Milo Bonser

Camarco (Financial PR)

Geoffrey Pelham-Lane +44 (0)7733 124 226

Ginny Pulbrook +44 (0)7961 315 138

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
      Details of the person discharging managerial responsibilities 
  1    / person closely associated 
 a)   Name                        Richard Fairman 
     --------------------------  --------------------------------------------- 
      Reason for the notification 
  2 
     ------------------------------------------------------------------------- 
 a)   Position/status             Chief Executive Officer 
     --------------------------  --------------------------------------------- 
 b)   Initial notification        Initial Notification 
       /Amendment 
     --------------------------  --------------------------------------------- 
      Details of the issuer, emission allowance market participant, 
  3    auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------------- 
 a)   Name                        CVS Group plc 
     --------------------------  --------------------------------------------- 
 b)   LEI                         213800J41XDQ2NX48O05 
     --------------------------  --------------------------------------------- 
      Details of the transaction(s): section to be repeated 
  4    for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ------------------------------------------------------------------------- 
 a)   Description of the          Ordinary shares of 0.2 pence each 
       financial instrument, 
       type of instrument 
                                   GB00B2863827 
       Identification code 
     --------------------------  --------------------------------------------- 
 b)   Nature of the transaction        i) Exercise of options under LTIP 
                                        14 
                                        ii) Sale of Ordinary shares arising 
                                        from exercise 
     --------------------------  --------------------------------------------- 
 c)   Price(s) and volume(s)        Price(s)                        Volume(s) 
                                                i) Exercise price 
                                                 of 0.2p             41,030 
                                                                      19,510 
                                                 ii) 1616.5321p 
                                                                    ---------- 
     --------------------------  --------------------------------------------- 
 d)   Aggregated information      N/A 
 
       - Aggregated volume 
 
 
       - Price 
     --------------------------  --------------------------------------------- 
 e)   Date of the transaction     6 October 2023 
     --------------------------  --------------------------------------------- 
 f)   Place of the transaction         i) Outside a trading venue 
                                        ii) London Stock Exchange, AIM. 
     --------------------------  --------------------------------------------- 
 
 
      Details of the person discharging managerial responsibilities 
  1    / person closely associated 
 a)   Name                        Ben Jacklin 
     --------------------------  -------------------------------------------- 
      Reason for the notification 
  2 
     ------------------------------------------------------------------------ 
 a)   Position/status             Deputy CEO 
     --------------------------  -------------------------------------------- 
 b)   Initial notification        Initial Notification 
       /Amendment 
     --------------------------  -------------------------------------------- 
      Details of the issuer, emission allowance market participant, 
  3    auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------------ 
 a)   Name                        CVS Group plc 
     --------------------------  -------------------------------------------- 
 b)   LEI                         213800J41XDQ2NX48O05 
     --------------------------  -------------------------------------------- 
      Details of the transaction(s): section to be repeated 
  4    for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ------------------------------------------------------------------------ 
 a)   Description of the          Ordinary shares of 0.2 pence each 
       financial instrument, 
       type of instrument 
                                   GB00B2863827 
       Identification code 
     --------------------------  -------------------------------------------- 
 b)   Nature of the transaction        i) Exercise of options under LTIP 
                                        14 
                                        ii) Sale of Ordinary shares arising 
                                        from exercise 
     --------------------------  -------------------------------------------- 
 c)   Price(s) and volume(s)       Price(s)                        Volume(s) 
                                               i) Exercise price 
                                                of 0.2p             24,618 
                                                                     11,706 
                                                ii) 1616.5321p 
                                                                   ---------- 
     --------------------------  -------------------------------------------- 
 d)   Aggregated information      N/A 
 
       - Aggregated volume 
 
 
       - Price 
     --------------------------  -------------------------------------------- 
 e)   Date of the transaction     6 October 2023 
     --------------------------  -------------------------------------------- 
 f)   Place of the transaction         i) Outside a trading venue 
                                        ii) London Stock Exchange, AIM. 
     --------------------------  -------------------------------------------- 
 
 
      Details of the person discharging managerial responsibilities 
  1    / person closely associated 
 a)   Name                        Robin Alfonso 
     --------------------------  -------------------------------------------- 
      Reason for the notification 
  2 
     ------------------------------------------------------------------------ 
 a)   Position/status             Chief Financial Officer 
     --------------------------  -------------------------------------------- 
 b)   Initial notification        Initial Notification 
       /Amendment 
     --------------------------  -------------------------------------------- 
      Details of the issuer, emission allowance market participant, 
  3    auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------------ 
 a)   Name                        CVS Group plc 
     --------------------------  -------------------------------------------- 
 b)   LEI                         213800J41XDQ2NX48O05 
     --------------------------  -------------------------------------------- 
      Details of the transaction(s): section to be repeated 
  4    for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ------------------------------------------------------------------------ 
 a)   Description of the          Ordinary shares of 0.2 pence each 
       financial instrument, 
       type of instrument 
                                   GB00B2863827 
       Identification code 
     --------------------------  -------------------------------------------- 
 b)   Nature of the transaction        i) Exercise of options under LTIP 
                                        14 
                                        ii) Sale of Ordinary shares arising 
                                        from exercise 
     --------------------------  -------------------------------------------- 
 c)   Price(s) and volume(s)       Price(s)                        Volume(s) 
                                               i) Exercise price 
                                                of 0.2p             13,540 
                                                                     6,439 
                                                ii) 1616.5321p 
                                                                   ---------- 
     --------------------------  -------------------------------------------- 
 d)   Aggregated information      N/A 
 
       - Aggregated volume 
 
 
       - Price 
     --------------------------  -------------------------------------------- 
 e)   Date of the transaction     6 October 2023 
     --------------------------  -------------------------------------------- 
 f)   Place of the transaction         i) Outside a trading venue 
                                        ii) London Stock Exchange, AIM. 
     --------------------------  -------------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCEADENESLDFFA

(END) Dow Jones Newswires

October 09, 2023 09:58 ET (13:58 GMT)

Cvs (LSE:CVSG)
Historical Stock Chart
From Jan 2024 to Feb 2024 Click Here for more Cvs Charts.
Cvs (LSE:CVSG)
Historical Stock Chart
From Feb 2023 to Feb 2024 Click Here for more Cvs Charts.